ImmunoPrecise Antibodies: CFO Resignation and the Road Ahead

ImmunoPrecise Antibodies Ltd. (IPA) has announced the resignation of its Chief Financial Officer (CFO), Kristin Taylor, effective January 16, 2025. Ms. Taylor will continue to serve in her role until that date and will remain available to the company on a consulting basis after that time. IPA has initiated a CFO succession process and will provide updates as appropriate.

Kristin Taylor has been a valued member of the IPA team over the past year, making significant contributions to the company's success, including the enhancement of IPA's planning and budgeting process. Her departure may have some short-term implications for the company's financial targets and long-term growth objectives.